Status: current, Defined. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3747622014 | Substance with programmed cell death protein 1 inhibitor mechanism of action (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3747623016 | Programmed cell death protein 1 inhibitor | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3747624010 | PD-1 inhibitor | en | Synonym | Inactive | Case sensitive | SNOMED CT core |
| 3969299018 | PD-1 (programmed cell death protein 1) inhibitor | en | Synonym | Active | Case sensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Programmed cell death protein 1 inhibitor | Is a | Effector | false | Inferred relationship | Some | ||
| Programmed cell death protein 1 inhibitor | Has disposition | Programmed cell death protein 1 inhibitor | true | Inferred relationship | Some | ||
| Programmed cell death protein 1 inhibitor | Is a | Immune checkpoint inhibitor | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Cemiplimab | Is a | True | Programmed cell death protein 1 inhibitor | Inferred relationship | Some | |
| Pembrolizumab | Is a | True | Programmed cell death protein 1 inhibitor | Inferred relationship | Some | |
| Atezolizumab | Is a | True | Programmed cell death protein 1 inhibitor | Inferred relationship | Some | |
| Nivolumab | Is a | True | Programmed cell death protein 1 inhibitor | Inferred relationship | Some | |
| Programmed cell death protein 1 inhibitor-containing product | Has active ingredient | True | Programmed cell death protein 1 inhibitor | Inferred relationship | Some | 1 |
| Dostarlimab | Is a | True | Programmed cell death protein 1 inhibitor | Inferred relationship | Some |
Reference Sets
Substance foundation reference set
FHIR